Arbor Rapha Capital Bioholdings Corp. I Units
ARCKU
ARCKU was delisted on the 12th of January, 2023.
2 hedge funds and large institutions have $269K invested in Arbor Rapha Capital Bioholdings Corp. I Units in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 12 closing their positions.
85% less funds holding
Funds holding: 13 → 2 (-11)
92% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 12
98% less capital invested
Capital invested by funds: $13.5M → $269K (-$13.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.02K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
-$6.05M |
| 2 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
-$3.46M |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
-$2.02M |
| 4 |
WC
Wealthspring Capital
West Harrison,
New York
|
-$567K |
| 5 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$505K |
ARCKU Hedge Fund Activity: Q4 2022 in Review
2 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Arbor Rapha Capital Bioholdings Corp. I Units (ARCKU) for Q4 2022, worth a combined $269K — down 98% from $13.5M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ARCKU and 1 opened new positions — a net loss of 11 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $1.02K. The largest seller was HGC Investment Management, exiting entirely with an estimated $6.05M sold.
- 2 institutional investors held Arbor Rapha Capital Bioholdings Corp. I Units (ARCKU) as of Q4 2022, down from 13 in Q3 2022.
- Funds reported $269K of Arbor Rapha Capital Bioholdings Corp. I Units stock for Q4 2022, down 98% quarter-over-quarter.
- 1 fund opened new Arbor Rapha Capital Bioholdings Corp. I Units positions in Q4 2022 and 12 closed out, a net change of -11 holders.
- The largest Arbor Rapha Capital Bioholdings Corp. I Units buyer in Q4 2022 was Tower Research Capital (TRC), an estimated $1.02K added.
- The largest Arbor Rapha Capital Bioholdings Corp. I Units seller in Q4 2022 was HGC Investment Management, an estimated $6.05M sold.
Based on aggregated 13F filings for Q4 2022.